ANDA 89099, held by Abraxis Pharmaceuticals. Sterile Water for Injection.
As of Nov 21, 2026, ANDA 89099 (Bacteriostatic Water for Injection In Plastic Container), held by Abraxis Pharmaceuticals, was not approved, with 0 approved supplements and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| Bacteriostatic Water for Injection In Plastic Container100% · liquid;n/a | Sterile Water for Injection | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters